Wolverine Asset Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25
Closed -$229 1762
2024
Q1
$229 Hold
25
﹤0.01% 1606
2023
Q4
$279 Sell
25
-15
-38% -$167 ﹤0.01% 1686
2023
Q3
$707 Buy
40
+3
+8% +$109 ﹤0.01% 1729
2023
Q2
$2.04K Sell
37
-39
-51% -$2.48K ﹤0.01% 1577
2023
Q1
$5.19K Sell
76
-92
-55% -$7.15K ﹤0.01% 1539
2022
Q4
$10.2K Sell
168
-37
-18% -$3.44K ﹤0.01% 1627
2022
Q3
$20K Sell
205
-67
-25% -$7.81K ﹤0.01% 1836
2022
Q2
$23K Sell
272
-66
-20% -$8.07K ﹤0.01% 1799
2022
Q1
$51K Buy
338
+211
+166% +$39.3K ﹤0.01% 1500
2021
Q4
$40K Buy
+127
New +$44.8K ﹤0.01% 1569
2021
Q3
Sell
-353
Closed -$105K 2277
2021
Q2
$105K Sell
353
-103
-23% -$30.7K ﹤0.01% 1466
2021
Q1
$136K Buy
456
+359
+370% +$110K ﹤0.01% 1365
2020
Q4
$29K Buy
+97
New +$28.5K ﹤0.01% 1409

Other funds holding RBOT

Wolverine Asset Management's RBOT Position: Q2 2024 in Review

Wolverine Asset Management sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 25 shares — an estimated $229 sold.

Wolverine Asset Management first reported a position in RBOT in Q4 2020 and held it in 13 quarters. The position peaked at $136K in Q1 2021. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Wolverine Asset Management reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 25 Vicarious Surgical shares in Q2 2024, an estimated $229.
  • Wolverine Asset Management first reported a position in Vicarious Surgical in Q4 2020 and held it in 13 quarters.
  • Wolverine Asset Management's Vicarious Surgical position peaked at $136K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.